Elisabeth G E de Vries

Elisabeth G E de Vries

UNVERIFIED PROFILE

Are you Elisabeth G E de Vries?   Register this Author

Register author
Elisabeth G E de Vries

Elisabeth G E de Vries

Publications by authors named "Elisabeth G E de Vries"

Are you Elisabeth G E de Vries?   Register this Author

100Publications

2093Reads

-Profile Views

Shortages of inexpensive essential medicines.

Lancet Oncol 2019 May 18;20(5):e224-e225. Epub 2019 Apr 18.

ESMO President, Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30248-7DOI Listing
May 2019

Consideration of breast cancer subtype in targeting the androgen receptor.

Pharmacol Ther 2019 May 8. Epub 2019 May 8.

Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01637258193007
Publisher Site
http://dx.doi.org/10.1016/j.pharmthera.2019.05.005DOI Listing
May 2019

Integrating molecular nuclear imaging in clinical research to improve anticancer therapy.

Nat Rev Clin Oncol 2019 Apr;16(4):241-255

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-018-0123-yDOI Listing
April 2019

ESMO-MCBS: setting the record straight.

Lancet Oncol 2019 Apr;20(4):e192

European Society for Medical Oncology-Magnitude of Clinical Benefit Scale Working Group, Lugano, Switzerland; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30174-3DOI Listing
April 2019

A review of bispecific antibodies and antibody constructs in oncology and clinical challenges.

Pharmacol Ther 2019 Apr 24. Epub 2019 Apr 24.

Departments of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2019.04.006DOI Listing
April 2019

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology.

ESMO Open 2019 6;4(2):e000460. Epub 2019 Mar 6.

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2018-000460DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435239PMC
March 2019

Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition.

Oncogene 2019 02 10;38(9):1477-1488. Epub 2018 Oct 10.

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, Netherlands.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41388-018-0522-7
Publisher Site
http://dx.doi.org/10.1038/s41388-018-0522-7DOI Listing
February 2019

Micro-computed tomography (micro-CT) for intraoperative surgical margin assessment of breast cancer: A feasibility study in breast conserving surgery.

Eur J Surg Oncol 2018 11 3;44(11):1708-1713. Epub 2018 Jul 3.

Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Department of Nuclear Medicine and Molecular Imaging and Intensive Care, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejso.2018.06.022DOI Listing
November 2018

Considering the biology of late recurrences in selecting patients for extended endocrine therapy in breast cancer.

Cancer Treat Rev 2018 Nov 26;70:118-126. Epub 2018 Jul 26.

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.07.015DOI Listing
November 2018

Androgen receptor expression inversely correlates with immune cell infiltration in human epidermal growth factor receptor 2-positive breast cancer.

Eur J Cancer 2018 11 9;103:52-60. Epub 2018 Sep 9.

Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.08.001DOI Listing
November 2018

Tumor-associated macrophages in breast cancer: Innocent bystander or important player?

Cancer Treat Rev 2018 Nov 28;70:178-189. Epub 2018 Aug 28.

Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.08.010DOI Listing
November 2018

Molecular imaging to enlighten cancer immunotherapies and underlying involved processes.

Cancer Treat Rev 2018 Nov 25;70:232-244. Epub 2018 Sep 25.

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03057372183016
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2018.09.007DOI Listing
November 2018

Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative F-FDG PET/CT analysis.

EJNMMI Res 2018 Nov 20;8(1):101. Epub 2018 Nov 20.

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, PO Box 30.001, 9700 RB, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13550-018-0453-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246760PMC
November 2018

RE: Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration.

J Natl Cancer Inst 2018 Oct;110(10):1142-1143

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy029DOI Listing
October 2018

Improving on Tail-of-the-Curve Evaluation With the American Society of Clinical Oncology Value Framework.

JAMA Oncol 2018 Oct;4(10):1437

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.3264DOI Listing
October 2018

Influence of protein properties and protein modification on biodistribution and tumor uptake of anticancer antibodies, antibody derivatives, and non-Ig scaffolds.

Med Res Rev 2018 09 10;38(6):1837-1873. Epub 2018 Apr 10.

Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21498DOI Listing
September 2018

Glypican 3 Overexpression across a Broad Spectrum of Tumor Types Discovered with Functional Genomic mRNA Profiling of a Large Cancer Database.

Am J Pathol 2018 Sep 21;188(9):1973-1981. Epub 2018 Jun 21.

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2018.05.014DOI Listing
September 2018

Preparing for the incoming wave of biosimilars in oncology.

ESMO Open 2018 5;3(6):e000420. Epub 2018 Sep 5.

Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2018-000420DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144900PMC
September 2018

F-Fluoroestradiol Tumor Uptake Is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients.

J Nucl Med 2018 Aug 30;59(8):1212-1218. Epub 2018 Mar 30.

Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.117.198846DOI Listing
August 2018

Zr-mAb3481 PET for HER3 tumor status assessment during lapatinib treatment.

MAbs 2017 Nov/Dec;9(8):1370-1378. Epub 2017 Sep 5.

b Departments of Clinical Pharmacy and Pharmacology , University of Groningen, University Medical Center Groningen , Groningen , The Netherlands.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/19420862.2017.1
Publisher Site
http://dx.doi.org/10.1080/19420862.2017.1371382DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680796PMC
July 2018

Molecular Imaging in Cancer Drug Development.

J Nucl Med 2018 05 25;59(5):726-732. Epub 2018 Jan 25.

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.116.188045DOI Listing
May 2018

Harnessing Integrative Omics to Facilitate Molecular Imaging of the Human Epidermal Growth Factor Receptor Family for Precision Medicine.

Theranostics 2017 27;7(7):2111-2133. Epub 2017 May 27.

Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/thno.17934DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479290PMC
March 2018

Evolution in sentinel lymph node biopsy in breast cancer.

Crit Rev Oncol Hematol 2018 Mar 20;123:83-94. Epub 2017 Sep 20.

Department of Surgery, University Medical Center Groningen, Groningen, The Netherlands; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2017.09.010DOI Listing
March 2018

In Vivo Quantification of ERβ Expression by Pharmacokinetic Modeling: Studies with F-FHNP PET.

J Nucl Med 2017 11 13;58(11):1743-1748. Epub 2017 Jul 13.

Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.117.192666DOI Listing
November 2017

Web-Based Tailored Psychoeducation for Breast Cancer Patients at the Onset of the Survivorship Phase: A Multicenter Randomized Controlled Trial.

J Pain Symptom Manage 2017 10 13;54(4):466-475. Epub 2017 Jul 13.

Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2017.07.009DOI Listing
October 2017

Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape.

ESMO Open 2017 9;2(4):e000272. Epub 2017 Oct 9.

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2017-000272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640100PMC
October 2017

Theranostics Using Antibodies and Antibody-Related Therapeutics.

J Nucl Med 2017 09;58(Suppl 2):83S-90S

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.116.186940DOI Listing
September 2017

Zr-Onartuzumab PET imaging of c-MET receptor dynamics.

Eur J Nucl Med Mol Imaging 2017 Aug 19;44(8):1328-1336. Epub 2017 Mar 19.

Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-017-3672-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486818PMC
August 2017

Human Epidermal Growth Factor Receptor 3-Specific Tumor Uptake and Biodistribution of Zr-MSB0010853 Visualized by Real-Time and Noninvasive PET Imaging.

J Nucl Med 2017 08 30;58(8):1210-1215. Epub 2017 Mar 30.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.116.181586DOI Listing
August 2017

Everolimus Effect on Gastrin and Glucagon in Pancreatic Neuroendocrine Tumors.

Pancreas 2017 07;46(6):751-757

From the *Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin/Campus Virchow Klinikum, Berlin, Germany; †Novartis Pharmaceuticals Corporation, East Hanover, NJ; ‡Department of Medical Oncology, University Medical Center, University of Groningen, Groningen, The Netherlands; §Oncologie Endocrinienne et Médecine Nucléaire, Institut Gustave-Roussy, Villejuif, France; and ∥Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000830DOI Listing
July 2017

Synthesis and Evaluation of the Estrogen Receptor β-Selective Radioligand 2-F-Fluoro-6-(6-Hydroxynaphthalen-2-yl)Pyridin-3-ol: Comparison with 16α-F-Fluoro-17β-Estradiol.

J Nucl Med 2017 Apr 1;58(4):554-559. Epub 2016 Dec 1.

Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.116.180158DOI Listing
April 2017

RECIST - learning from the past to build the future.

Nat Rev Clin Oncol 2017 03 20;14(3):187-192. Epub 2016 Dec 20.

EORTC Headquarters, Avenue E Mounier 83/11, 1200 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2016.195DOI Listing
March 2017

Pancreatic Uptake by 18F-FDOPA PET/CT in Patients With Hypoglycemia After Gastric Bypass Surgery Compared With Controls With or Without Carbidopa Pretreatment.

Clin Nucl Med 2017 Mar;42(3):163-168

From the *Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen; †Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden; Departments of ‡Nuclear Medicine and Molecular Imaging, and §Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001496DOI Listing
March 2017

Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer.

J Natl Cancer Inst 2017 01 13;109(1). Epub 2016 Oct 13.

Affiliations of authors: Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands (RDB, MATMvV, EGEdV, CPS, RSNF); Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium (CS, MJPG); Division of Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands (JBAGH).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284248PMC
January 2017

Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study.

J Clin Oncol 2016 11 30;34(32):3906-3913. Epub 2016 Sep 30.

James C. Yao, University of Texas MD Anderson Cancer Center, Houston, TX; Maurizio Voi, Wei He, and David Chen, Novartis, East Hanover, NJ; Timothy Hobday, Mayo Clinic College of Medicine, Rochester, MN; Rodney Pommier, Oregon Health & Science University, Portland, OR; Marianne Pavel, Charité Universitätsmedizin, Berlin, Germany; Catherine Lombard-Bohas, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; Eric Van Cutsem, University Hospitals Gasthuisberg/Leuven and KU Leuven, Leuven, Belgium; Ulrike Brandt, Novartis Pharma AG, Basel, Switzerland; Jaume Capdevila, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Elisabeth G. E. de Vries, UMCG, University of Groningen, Groningen, Netherlands; Paola Tomassetti, University of Bologna, Bologna, Italy; and Kjell Öberg, Uppsala University Hospital, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2016/09/07/JCO.2016.68
Web Search
http://dx.doi.org/10.1200/JCO.2016.68.0702DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791842PMC
November 2016

Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer 89Zr-imgatuzumab.

Oncotarget 2016 Oct;7(42):68111-68121

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.11827DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356542PMC
October 2016

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.

Authors:
Christian Dittrich Michael Kosty Svetlana Jezdic Doug Pyle Rossana Berardi Jonas Bergh Nagi El-Saghir Jean-Pierre Lotz Pia Österlund Nicholas Pavlidis Gunta Purkalne Ahmad Awada Susana Banerjee Smita Bhatia Jan Bogaerts Jan Buckner Fatima Cardoso Paolo Casali Edward Chu Julia Lee Close Bertrand Coiffier Roisin Connolly Sarah Coupland Luigi De Petris Maria De Santis Elisabeth G E de Vries Don S Dizon Jennifer Duff Linda R Duska Alexandru Eniu Marc Ernstoff Enriqueta Felip Martin F Fey Jill Gilbert Nicolas Girard Andor W J M Glaudemans Priya K Gopalan Axel Grothey Stephen M Hahn Diana Hanna Christian Herold Jørn Herrstedt Krisztian Homicsko Dennie V Jones Lorenz Jost Ulrich Keilholz Saad Khan Alexander Kiss Claus-Henning Köhne Rainer Kunstfeld Heinz-Josef Lenz Stuart Lichtman Lisa Licitra Thomas Lion Saskia Litière Lifang Liu Patrick J Loehrer Merry Jennifer Markham Ben Markman Marius Mayerhoefer Johannes G Meran Olivier Michielin Elizabeth Charlotte Moser Giannis Mountzios Timothy Moynihan Torsten Nielsen Yuichiro Ohe Kjell Öberg Antonio Palumbo Fedro Alessandro Peccatori Michael Pfeilstöcker Chandrajit Raut Scot C Remick Mark Robson Piotr Rutkowski Roberto Salgado Lidia Schapira Eva Schernhammer Martin Schlumberger Hans-Joachim Schmoll Lowell Schnipper Cristiana Sessa Charles L Shapiro Julie Steele Cora N Sternberg Friedrich Stiefel Florian Strasser Roger Stupp Richard Sullivan Josep Tabernero Luzia Travado Marcel Verheij Emile Voest Everett Vokes Jamie Von Roenn Jeffrey S Weber Hans Wildiers Yosef Yarden

ESMO Open 2016 29;1(5):e000097. Epub 2016 Sep 29.

Department of General Medical Oncology , University Hospitals Leuven , Leuven , Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2016-000097DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070299PMC
September 2016

Development, preclinical safety, formulation, and stability of clinical grade bevacizumab-800CW, a new near infrared fluorescent imaging agent for first in human use.

Eur J Pharm Biopharm 2016 Jul 12;104:226-34. Epub 2016 May 12.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejpb.2016.05.008DOI Listing
July 2016

Emerging Opportunities for c-MET Visualization in the Clinic.

J Nucl Med 2016 05 28;57(5):663-4. Epub 2016 Jan 28.

Department of Medical Oncology, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.169771DOI Listing
May 2016

Biodistribution and PET Imaging of Labeled Bispecific T Cell-Engaging Antibody Targeting EpCAM.

J Nucl Med 2016 05 4;57(5):812-7. Epub 2016 Feb 4.

Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.168153DOI Listing
May 2016

VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside.

Oncotarget 2016 Apr;7(16):21247-58

Department of Medical Oncology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.6918DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008282PMC
April 2016

Imaging Diagnostic and Therapeutic Targets: Human Epidermal Growth Factor Receptor 2.

J Nucl Med 2016 Feb;57 Suppl 1:81S-8S

Department of Nuclear Medicine, Institut Jules Bordet-Université Libre de Bruxelles (ULB), Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.157941DOI Listing
February 2016

Translation of New Molecular Imaging Approaches to the Clinical Setting: Bridging the Gap to Implementation.

J Nucl Med 2016 Feb;57 Suppl 1:96S-104S

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.157974DOI Listing
February 2016

Breaking the DNA damage response to improve cervical cancer treatment.

Cancer Treat Rev 2016 Jan 24;42:30-40. Epub 2015 Nov 24.

Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2015.11.008DOI Listing
January 2016

Immunotherapeutic options on the horizon in breast cancer treatment.

Pharmacol Ther 2015 Dec 24;156:90-101. Epub 2015 Sep 24.

Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands; University of Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2015.09.003DOI Listing
December 2015

Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy.

Eur J Nucl Med Mol Imaging 2015 Oct 20;42(11):1674-1681. Epub 2015 Jun 20.

Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-015-3107-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554736PMC
October 2015

Functional genomic mRNA profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types.

Oncotarget 2015 Sep;6(29):28164-72

University of Groningen, University Medical Center Groningen, Department of Medical Oncology, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.4461DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695051PMC
September 2015

Human stromal cells are required for an anti-breast cancer effect of zoledronic acid.

Oncotarget 2015 Sep;6(27):24436-47

Department of Medical Oncology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.4421DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695196PMC
September 2015

Dopamine and serotonin regulate tumor behavior by affecting angiogenesis.

Drug Resist Updat 2014 Oct-Dec;17(4-6):96-104. Epub 2014 Sep 22.

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drup.2014.09.001DOI Listing
August 2015

Molecular Imaging As a Tool for Drug Development and Trial Design.

J Clin Oncol 2015 Aug 13;33(24):2585-7. Epub 2015 Jul 13.

University Medical Center Groningen, University of Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.6425DOI Listing
August 2015

Rif1 Is Required for Resolution of Ultrafine DNA Bridges in Anaphase to Ensure Genomic Stability.

Dev Cell 2015 Aug 6;34(4):466-74. Epub 2015 Aug 6.

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9723 GZ Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.devcel.2015.06.014DOI Listing
August 2015

Internet-based support programs to alleviate psychosocial and physical symptoms in cancer patients: a literature analysis.

Crit Rev Oncol Hematol 2015 Jul 31;95(1):26-37. Epub 2015 Jan 31.

Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10408428150001
Publisher Site
http://dx.doi.org/10.1016/j.critrevonc.2015.01.011DOI Listing
July 2015

Antibody positron emission tomography imaging in anticancer drug development.

J Clin Oncol 2015 May 16;33(13):1491-504. Epub 2015 Mar 16.

Laetitia E. Lamberts, Anton G.T. Terwisscha van Scheltinga, Marjolijn N. Lub-de Hooge, Carolien P. Schröder, Jourik A. Gietema, Adrienne H. Brouwers, and Elisabeth G.E. de Vries, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; and Simon P. Williams, Genentech, South San Francisco, CA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/13/1491.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.57.8278
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.57.8278DOI Listing
May 2015

Regulators of homologous recombination repair as novel targets for cancer treatment.

Front Genet 2015 20;6:96. Epub 2015 Mar 20.

Department of Medical Oncology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen Groningen, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fgene.2015.00096DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367534PMC
April 2015

A phase Ib study of the VEGF receptor tyrosine kinase inhibitor tivozanib and modified FOLFOX-6 in patients with advanced gastrointestinal malignancies.

Clin Colorectal Cancer 2015 Mar 16;14(1):18-24.e1. Epub 2014 Dec 16.

Department of Medical Oncology, Erasmus University Cancer Institute, Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2014.12.001DOI Listing
March 2015

Objective allergy markers and risk of cancer mortality and hospitalization in a large population-based cohort.

Cancer Causes Control 2015 Jan 12;26(1):99-109. Epub 2014 Nov 12.

Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-014-0489-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282688PMC
January 2015

Assessment of estrogen receptor expression in epithelial ovarian cancer patients using 16α-18F-fluoro-17β-estradiol PET/CT.

J Nucl Med 2015 Jan 4;56(1):50-5. Epub 2014 Dec 4.

Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.114.147579DOI Listing
January 2015

Words matter: distinguishing "personalized medicine" and "biologically personalized therapeutics".

J Natl Cancer Inst 2014 Dec 7;106(12). Epub 2014 Oct 7.

Cancer Pain and Palliative Medicine Service, Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel (NIC); Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands (EGEdV); Kellog School of Management and Northwestern University Medical School, Chicago, IL (LE); Sussex Health Outcomes Research & Education in Cancer (SHORE-C),Brighton & Sussex Medical School, University of Sussex, Falmer, UK (LF); Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia (PAF); Department of Oncology, Shaare Zedek Medical Center, and Hebrew University-School of Medicine, Jerusalem, Israel (AG); Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium (MJP); Department of Otolaryngology and Oncology, Johns Hopkins University, Baltimore, MD (DS); Oncotest/Verify, Teva Pharmaceutical Industries, Petach Tikva, Israel (LS-G); Melabev Community Elders Care Research Department, Jerusalem, Israel (CT).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju321DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568994PMC
December 2014

APC/C(Cdh1) controls CtIP stability during the cell cycle and in response to DNA damage.

EMBO J 2014 Dec 27;33(23):2860-79. Epub 2014 Oct 27.

Department of Medical Oncology, University Medical Center Groningen University of Groningen, Groningen, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.15252/embj.201489017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282561PMC
December 2014

CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model.

Clin Exp Metastasis 2014 Oct 26;31(7):829-39. Epub 2014 Aug 26.

Departments of Medical Oncology, University Medical Center Groningen, University of Groningen, P.O. Box 30.00, 19700 RB, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10585-014-9673-2DOI Listing
October 2014

Considerations on absence of 68Ga-DOTA-F(ab')2-trastuzumab tracer uptake in HER2-overexpressing tumor lesions.

Nucl Med Commun 2014 Jul;35(7):785-6

aDepartment of Clinical Pharmacy, Medisch Spectrum Twente, Enschede Departments of bNuclear Medicine and Molecular Imaging cMedical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0000000000000123DOI Listing
July 2014